Skip Nav

Education Materials

HIV Vaccine Awareness Day


May 18, 2012



logo

May 18 is the 15th annual observance of HIV Vaccine Awareness Day. This day provides an opportunity to recognize the volunteers, community members, health professionals, and scientists working together toward finding an HIV vaccine. This day is also an opportunity to educate communities across the United States about the importance of HIV vaccine research.

Two types of experimental HIV vaccines are currently being studied in clinical trials. Therapeutic HIV vaccines are designed to treat HIV-infected people. Preventive HIV vaccines are designed to prevent HIV infection in people who do not already have HIV. Even though no HIV vaccines are currently available or approved by the Food and Drug Administration (FDA), significant research is under way to develop an effective vaccine.

There is scientific evidence that a safe and effective HIV vaccine may be possible. For the first time, in a research study in Thailand, an experimental vaccine demonstrated some ability to prevent HIV infection among vaccinated individuals. The 2009 research findings represent an important advance in HIV vaccine research. More research is needed but the study results bring researchers a step closer to developing a broadly protective HIV vaccine.

The links on this page provide information about HIV Vaccine Awareness Day and resources to learn more about progress in HIV vaccine research.
 


HIV Vaccine Awareness Day Webpages

2012 Statement by Dr. Anthony S. Fauci, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), on HIV Vaccine Awareness Day [en español]

NIAID HIV Vaccine Awareness Day Webpage 

HIV Vaccine Trials Network (HVTN) HIV Vaccine Awareness Day Webpage 

AIDS.gov HIV Vaccine Awareness Day Webpage

AIDS.gov HIV Vaccine Awareness Day Video

Vaccines.gov HIV Vaccine Awareness Day Webpage 


logo
 

HIV Vaccine Research

FY 2012 Trans-NIH Plan for HIV-Related Research: Comprehensive plan for all NIH HIV-related research for 2012, from the Office of AIDS Research (OAR), NIH. Information on vaccine research is included in the section on Reducing New Infections.

Clinical Trials About HIV Vaccines:
Studies (clinical trials) seeking volunteers to participate in HIV vaccine research, from AIDSinfo.

To help narrow your search for clinical trials, AIDSinfo provides one-on-one assistance via the Internet (Live Chat) or over the phone (1-800-448-0440).

Research About HIV Vaccines:
Published research about HIV vaccines, from PubMed.gov.

Summaries of journal articles about HIV vaccines, from the Education Resources Information Center (ERIC).

logo
 

Resources from Partners in HIV Vaccine Research

NIAID: Federal agency that supports research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS. NIAID supports a number of HIV vaccine trials around the world through several internal and external organizations.

The Dale and Betty Bumpers Vaccine Research Center (VRC): NIAID facility that conducts research to develop effective vaccines for human disease, in particular the development of vaccines for HIV.

Be the Generation: An HIV/AIDS education initiative created by NIAID. The initiative promotes awareness and support for prevention research, including HIV vaccine research.

Centers for Disease Control and Prevention (CDC): A federal agency that protects the health and safety of people at home and abroad through health promotion; prevention and control of disease, injury, and disability; and preparedness for new health threats. CDC HIV vaccine research is focused on conducting and evaluating HIV research studies in the United States and elsewhere.

HVTN: A NIAID-supported international organization of scientists and educators searching for an effective and safe preventive HIV vaccine. The organization conducts HIV vaccine research studies in cities on four continents.

U.S. Military HIV Research Program (MHRP): A U.S. Army-led program that works to protect U.S. troops from HIV infection and to reduce the global impact of the disease. The program’s primary focus is to develop a globally effective HIV-1 vaccine.


logo
 

AIDSinfo Resources

AIDSinfo and infoSIDA, its Spanish-language companion website, provide HIV/AIDS treatment and research information in both English and Spanish. These resources are also available on the AIDSinfo mobile site and the infoSIDA mobile site. AIDSinfo resources include:   
 

  • HIV/AIDS Clinical Trials [en español]: Database of clinical trials to help consumers and health care providers locate trials studying HIV/AIDS, including trials studying preventive and therapeutic HIV vaccines.
     
  • HIV/AIDS Clinical Guidelines: Federally approved medical practice guidelines related to HIV/AIDS. 
     
  • Glossary of HIV/AIDS-Related Terms [en español]: Dictionary of terms related to HIV/AIDS.
     
  • HIV/AIDS Education Materials [en español]: An assortment of easy-to-read fact sheets and other materials on HIV/AIDS-related topics.
     
  • HIV/AIDS Health Topics [en español]: Comprehensive collection of links to government resources about HIV/AIDS-related topics.
     
  • Live Chat [en español]: One-on-one assistance via the Internet to help people navigate the AIDSinfo website and get federally approved information on HIV/AIDS treatment and prevention research, HIV/AIDS clinical trials, and clinical guidelines. Over-the-phone assistance in English or Spanish is also available by calling AIDSinfo at 1-800-448-0440.

logo